Paras Healthcare has received the Securities and Exchange Board of India’s (SEBI's) approval to float an initial public offering (IPO). The company’s proposed IPO is a mix of fresh issue of equity shares of aggregating up to Rs 400 crore and an Offer for Sale (OFS) of up to 1.5 crore shares by a promoter and an investor shareholder. The company's equity shares are proposed to be listed on the BSE and NSE.
The company proposes to utilise the proceeds from the fresh issue for payment of debt; investment in subsidiaries, Paras Healthcare (Ranchi) and Plus Medicare Hospitals, in the form of debt or equity for payment of borrowings and for general corporate purposes. ICICI Securities, IIFL Securities and Motilal Oswal Investment Advisors are the book-running lead managers to the public issue.
Paras Healthcare offers several clinical specialties across hospitals, including cardiac sciences, oncology, neurosciences, gastrosciences, orthopaedics and joint replacement. It focuses on providing specialised tertiary medical care in Tier 2 and 3 cities.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7248.75 |
Max Healthcare Inst | 1166.60 |
Narayana Hrudayalay | 1286.30 |
Aster DM Healthcare | 486.85 |
Global Health | 1098.95 |
View more.. |